Donate Now
Fundraise
About Us
Who We Are
Mission & History
Board of Directors
Scientific Advisory Board
FAdult Council
Staff
Financials
Diversity, Equity, Inclusion
Privacy Policy
News
Contact
What We Do
Research
Support & Education
Fundraising
Events
International Support
Our Impact
Patients & Caregivers
Disease Information
Newly Diagnosed
What is Fanconi Anemia
Treatment
Relationship to Cancer
Clinical Care Guidelines
Clinical Trials & Research Opportunities
Info to Share with Your Doctor
FA Patient Registry
Tissue Donation
Virtual Tumor Board
Support Resources
Enroll with FARF Family Services
Caregiver Support
Grief Support
Online Support Groups
FA Family Retreat
Retreat for Adults with FA
International Support
Award for Adults with FA
Events
Education Resources
Resource Library
News & Community Blog
Podcasts
Related Resources & Organizations
FA Family Newsletter
Researchers & Doctors
Funding Opportunities
Research Grant Awards
Joel Walker Cancer Series
FA Research
Research Overview
Supported Research
Meet Our Researchers
Cancer Consortium
Gene Therapy
Relationship to Cancer
Stand Up To Cancer Project
Scientific Symposium
Resources
FA Research Materials
Clinical Care Guidelines
FA 101
How to Help
Ways to Give
Donate
Monthly Giving
Estate Giving
Employer Matching Gifts
Stock Gifts
Memorials
Foundations & Donor Advised Funds
Other Ways to Give (IRA, in-kind)
Volunteer
Create a Fundraiser
Find a Fundraiser
Fundraising Materials
Make Cards for the Community
Register or Login
May is Fanconi Anemia Month! Learn how you can get involved! >>
Let's Go!
Login
×
Username
Password
Show my name in the online users list
Auto-login on future visits
Leave unchecked if you're on a public computer.
Forgot your password?
Ruud Brakenhoff, PhD
Researchers
VU University Medical Center
Amsterdam, Netherlands
FA Research Projects
2012 - Targeted treatment of oral cancer and precancer in FA patients
2005 - Genetic Progression of FA-SCC and Development of a Non-Invasive Screening Method for Precursor Lesions
2003 - Development of Virotherapy Using Retargeted Adenoviruses to Eradicate Preneopolastic Lesions for the Oral Cavity and Oropharynx
See all Researchers
